Cleared Traditional

K232053 - SimpleSense-BP

K232053 is an FDA 510(k) clearance for SimpleSense-BP, manufactured by Nanowear, Inc.. The device is a Class 2 Cardiovascular device with product code DXN cleared through the Traditional 510(k) pathway after a 150-day FDA review.

K232053 · Nanowear, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2023
Decision
150d
Days
Class 2
Risk

K232053 is an FDA 510(k) clearance for the SimpleSense-BP, SimpleSense-BP Software Application. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Nanowear, Inc. (Brooklyn, US). The FDA issued a Cleared decision on December 8, 2023 after a review of 150 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Nanowear, Inc. devices

FDA 510(k) Submission Details - K232053

510(k) Number K232053 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 11, 2023
Decision Date December 08, 2023
Days to Decision 150 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
25d slower than avg
Panel avg: 125d · This submission: 150d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXN Device Classification - Class 2, Special Controls

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 565
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K232053.
Blood Pressure Monitor
K233130 · Guangdong Transtek Medical Electronics Co., Ltd. · Dec 2023
Digital Blood Pressure Monitor (Model: YB-800)
K231478 · Wenzhou Yosun Medical Technology Co.,Ltd · Dec 2023
Wrist Blood Pressure Monitor
K232815 · Zhuhai Yueja Medical Device Technology Co., Ltd. · Dec 2023
Electronic Blood Pressure Monitor, model: HTD6602US
K223170 · Hetaida Technology Co., Ltd. · Dec 2023
Electronic Blood Pressure Monitor
K232814 · Zhuhai Yueja Medical Device Technology Co., Ltd. · Dec 2023
Digital Blood Pressure Monitor
K231250 · Guangdong Genial Technology Co., Ltd. · Nov 2023